Oral contraceptives and human papillomavirus infection in cervical intraepithelial neoplasia

Arch Gynecol Obstet. 1992;252(1):25-30. doi: 10.1007/BF02389603.

Abstract

We report about 142 patients from whom colposcopically directed cervical punch biopsies were taken which showed condylomatous lesions with or without cervical intraepithelial neoplasia (CIN). Fifty-six (39.4%) of these women used oral contraceptives (OC) for at least two years before examination. We used DNA in situ hybridization on all biopsies for detection of human papillomavirus (HPV)-DNA. Among OC users a significant trend towards higher HPV infection rates in high grade CIN (odds ratio 2.9, P less than 0.05) was found, whereas non-users of oral contraceptives had the highest HPV infection rate in condylomatous lesions without CIN (odds ratio 0.5, P less than 0.05). Thus in OC users HPV infection was about 24 times more likely in CIN III as in condyloma, while among non-users the trend was the other way round (7-fold likelihood of HPV positivity in condyloma compared to CIN III). Other known risk factors for cervical carcinoma did not influence HPV infection rates in either group.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age Factors
  • Cervix Uteri / pathology
  • Condylomata Acuminata / chemically induced*
  • Condylomata Acuminata / pathology
  • Contraceptives, Oral / administration & dosage
  • Contraceptives, Oral / adverse effects*
  • DNA Probes, HPV*
  • Female
  • Humans
  • Neoplasm Staging
  • Odds Ratio
  • Papillomaviridae / drug effects*
  • Papillomaviridae / isolation & purification
  • Parity
  • Precancerous Conditions / chemically induced*
  • Precancerous Conditions / pathology
  • Risk
  • Risk Factors
  • Smoking / adverse effects
  • Smoking / pathology
  • Tumor Virus Infections / chemically induced*
  • Tumor Virus Infections / pathology
  • Uterine Cervical Neoplasms / chemically induced*
  • Uterine Cervical Neoplasms / pathology
  • Vaginal Smears

Substances

  • Contraceptives, Oral
  • DNA Probes, HPV